News
Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement

29 October 2024

News
The pricing announcement from the Center for Medicare Services became effective on October 1, 2024, and allows BioStem to begin marketing initiatives with Venture Medical

29 October 2024

News
Conference Call and Webcast to be held at 4:30 PM ET

28 October 2024

The ThinkEquity Conference 2024
Presentation to be Webcast Live at 11:30 a.m. Eastern

28 October 2024

The ThinkEquity Conference 2024
Bangalore, India, October 28, 2024 - PRISM MediaWire - Zoomcar Holdings, Inc. (“Zoomcar” or the “Company”) (Nasdaq: ZCAR), the Nasdaq-listed leading marketplace for self-drive car sharing, today announced that it will be participating in The ThinkEquity Conference on Oct...

28 October 2024

News
NEW YORK, October 25, 2024 - PRISM MediaWire - Bubblr Inc., d/b/a Ethical Web AI (OTC: BBLR) - a frontrunner in ethical technology determined to revolutionize the digital domain, has announced its new CEO, Manfred Ebensberger.

25 October 2024

The ThinkEquity Conference 2024
ENGLEWOOD, Colo., October 24, 2024 - XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI Aerospace" or the "Company") today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. Past ThinkEquity confe...

24 October 2024

The ThinkEquity Conference 2024
EDEN PRAIRIE, Minn., October 24, 2024 - PRISM MediaWire - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological...

24 October 2024

The ThinkEquity Conference 2024
CAPE CANAVERAL, FL, October 24, 2024 - PRISM MediaWire - Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), an innovative, agile space mission enabler, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Or...

24 October 2024

The ThinkEquity Conference 2024
Princeton, NJ, October 24, 2024 - PRISM MediaWire - Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today ...

24 October 2024

5
6
7
8
9
10
11
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.